ARMY APPLICATIONS LAB BROAD AGENCY ANNOUNCEMENT FOR DISRUPTIVE APPLICATIONS
grants.gov
This BAA sets forth research areas of interest to the Army Applications Lab (AAL). This BAA is issued under paragraph 6.102(d)(2) of the Federal Acqui...
GrantMixedUnited StatesOpen
AmountNot provided on the source page. Please check the official source.
DeadlineApr 4, 2029
This BAA sets forth research areas of interest to the Army Applications Lab (AAL). This BAA is issued under paragraph 6.102(d)(2) of the Federal Acquisition Regulation (FAR), which provides for the competitive selection of basic and applied research proposals, and 10 U.S.C. 2358, 10 U.S.C. 2371, and 10 U.S.C. 2371b, which provide the authorities for issuing awards under this announcement for basic and applied research. The definitions of basic and applied research may be found at 32 Code of Federal Regulations (CFR) 22.105. The definitions of basic and applied research may be found at 32 Code of Federal Regulations (CFR) 22.105. Proposals submitted in response to this BAA and selected for award are considered to be the result of full and open competition and in full compliance with the provision of Public Law 98- 369, "The Competition in Contracting Act of 1984" and subsequent amendments.
TEN
Germany – General personnel services for the government – Dynamisches Beschaffungssystem - Arbeitnehmerüberlassung (ANÜ)
NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
grants.gov
The NIH Phase IIB Strategic Breakthrough award bridges the funding gap between the end of a Small Business Innovation Research (SBIR) and Small Busine...
GrantCash GrantUnited StatesOpen
AmountNot provided on the source page. Please check the official source.
DeadlineApr 5, 2029
The NIH Phase IIB Strategic Breakthrough award bridges the funding gap between the end of a Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase II award and commercialization. The Phase IIB Strategic Breakthrough provides previously funded NIH SBIR or STTR projects additional support for later-stage research and development (R&D).
GRA
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
grants.gov
The Commercialization Readiness Pilot (CRP) program helps small business concerns (SBCs) move NIH-funded SBIR or STTR projects from late-stage develop...
GrantCash GrantUnited StatesOpen
AmountNot provided on the source page. Please check the official source.
DeadlineApr 5, 2029
The Commercialization Readiness Pilot (CRP) program helps small business concerns (SBCs) move NIH-funded SBIR or STTR projects from late-stage development to commercialization. The CRP supports later-stage research and development (R&D) and/or technical assistance that Phase II and Phase IIB Strategic Breakthrough awards do not typically support. This includes:Independent replication or confirmation of key studiesIND- or IDE-enabling studiesClinical studiesManufacturing scale-up and related quality activitiesRegulatory and other specialized technical supportSBCs may subcontract (outsource) a significant amount of the work in a CRP to meet the project goals.
TEN
France – Other passenger cars – Achat de véhicules et de matériels de travaux publics d'occasion pour les besoins du Département de la Côte-d'Or
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Teduglutid, ATC A16AX08 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum WS Bimatoprost (ausschl. in der Wirkstärke 0,1mg/ml), ATC S01EE03 f. d. Z. 01.6.26-31.5.28 (zzgl. V.-Option 1x12 Mon)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Methylprednisolon, ATC D07AC14 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Dalbavancin, ATC J01XA04 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tianeptin, ATC N06AX14 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Fondaparinux, ATC B01AX05 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Mesalazin (ausschl. Dafo TMR), ATC A07EC02 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. V.-Option 1x12 Mon)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ganirelix, ATC H01CC01 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Piperacillin + Tazobactam, ATC J01CR05 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. V.-Option 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Clobazam (ausschl. Dafo TAB), ATC N05BA09 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. V.-Option 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Gentamicin, ATC S01AA11 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Prednicarbat, ATC D07AC18 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Pomalidomid, ATC L04AX06 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Clobazam (ausschl. Dafo SUE), ATC N05BA09 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. V.-Option 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Bexaroten, ATC L01XF03 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. Verlängerungsoption 1x12 Monate)
Lithuania – Insurance services – Draudimo paslaugos, VU297
ted.europa.eu
Buyer: Vilniaus universitetas | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2029-04-05
TenderProcurement ContractLithuaniaOpen
AmountNot provided on the source page. Please check the official source.
DeadlineApr 5, 2029
Buyer: Vilniaus universitetas | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2029-04-05
TEN
Lithuania – Insurance services – Draudimo paslaugos, VU297
ted.europa.eu
Buyer: Vilniaus universitetas | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2029-04-05
TenderProcurement ContractLithuaniaOpen
AmountNot provided on the source page. Please check the official source.
DeadlineApr 5, 2029
Buyer: Vilniaus universitetas | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2029-04-05
No saved opportunities on this page
Use the star icon near an opportunity title to add it to Favorites.
📅 Best viewed on desktop - or rotate your phone to landscape mode.
#
Opportunity
Type
Region / Country
Amount
Deadline
Source
42351
France – Motor vehicles – Système d'acquisition dynamique pour l'achat de véhicules neufs et d'occasion pour la Région Grand EstBuyer: Région Grand Est | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2029-04-03
Tender
Procurement Contract
France
Not provided on the source page. Please check the official source.
Buyer: Région Grand Est | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2029-04-03
42352
Lithuania – Hire of goods-transport vehicles with driver – 1965 Mechanizmų ir automobilių nuoma su operatoriumi (DPS I)Buyer: Uždaroji akcinė bendrovė "GRINDA" | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2029-...
Tender
Procurement Contract
Lithuania
Not provided on the source page. Please check the official source.
ARMY APPLICATIONS LAB BROAD AGENCY ANNOUNCEMENT FOR DISRUPTIVE APPLICATIONSThis BAA sets forth research areas of interest to the Army Applications Lab (AAL). This BAA is issued under paragraph 6.102(d)(2)...
Grant
Mixed
United States
Not provided on the source page. Please check the official source.
This BAA sets forth research areas of interest to the Army Applications Lab (AAL). This BAA is issued under paragraph 6.102(d)(2) of the Federal Acquisition Regulation (FAR), which provides for the competitive selection of basic and applied research proposals, and 10 U.S.C. 2358, 10 U.S.C. 2371, and 10 U.S.C. 2371b, which provide the authorities for issuing awards under this announcement for basic and applied research. The definitions of basic and applied research may be found at 32 Code of Federal Regulations (CFR) 22.105. The definitions of basic and applied research may be found at 32 Code of Federal Regulations (CFR) 22.105. Proposals submitted in response to this BAA and selected for award are considered to be the result of full and open competition and in full compliance with the provision of Public Law 98- 369, "The Competition in Contracting Act of 1984" and subsequent amendments.
42354
Germany – General personnel services for the government – Dynamisches Beschaffungssystem - Arbeitnehmerüberlassung (ANÜ)Buyer: Flughafen Köln/Bonn GmbH | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2029-04-04
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)The NIH Phase IIB Strategic Breakthrough award bridges the funding gap between the end of a Small Business Innovation Research (SB...
Grant
Cash Grant
United States
Not provided on the source page. Please check the official source.
The NIH Phase IIB Strategic Breakthrough award bridges the funding gap between the end of a Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase II award and commercialization. The Phase IIB Strategic Breakthrough provides previously funded NIH SBIR or STTR projects additional support for later-stage research and development (R&D).
42356
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)The Commercialization Readiness Pilot (CRP) program helps small business concerns (SBCs) move NIH-funded SBIR or STTR projects fro...
Grant
Cash Grant
United States
Not provided on the source page. Please check the official source.
The Commercialization Readiness Pilot (CRP) program helps small business concerns (SBCs) move NIH-funded SBIR or STTR projects from late-stage development to commercialization. The CRP supports later-stage research and development (R&D) and/or technical assistance that Phase II and Phase IIB Strategic Breakthrough awards do not typically support. This includes:Independent replication or confirmation of key studiesIND- or IDE-enabling studiesClinical studiesManufacturing scale-up and related quality activitiesRegulatory and other specialized technical supportSBCs may subcontract (outsource) a significant amount of the work in a CRP to meet the project goals.
42357
France – Other passenger cars – Achat de véhicules et de matériels de travaux publics d'occasion pour les besoins du Département de la Côte-d'OrBuyer: Conseil Départemental de Côte d'Or (21) | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline:...
Tender
Procurement Contract
France
Not provided on the source page. Please check the official source.
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum WS Bimatoprost (ausschl. in der Wirkstärke 0,1mg/ml), ATC S01EE03 f. d. Z. 01.6.26-31.5.28 (zzgl. V.-Option 1x12 Mon)Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-04-05
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
